Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Medtronic
McKesson
Johnson and Johnson
Colorcon

Last Updated: August 19, 2022

Investigational Drug Information for Molybdenum


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug Molybdenum?

Molybdenum is an investigational drug.

There have been 12 clinical trials for Molybdenum. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Hepatolenticular Degeneration, Metal Metabolism, Inborn Errors, and Syndrome. The leading clinical trial sponsors are Alexion Pharmaceuticals, Alexion Pharma GmbH, and Origin Biosciences.

There are forty-eight US patents protecting this investigational drug and five hundred and thirty international patents.

Recent Clinical Trials for Molybdenum
TitleSponsorPhase
Study of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy ParticipantsAlexion PharmaceuticalsPhase 1
Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840Alexion PharmaceuticalsPhase 2
Phase 1 Study of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants.Alexion PharmaceuticalsPhase 1

See all Molybdenum clinical trials

Clinical Trial Summary for Molybdenum

Top disease conditions for Molybdenum
Top clinical trial sponsors for Molybdenum

See all Molybdenum clinical trials

US Patents for Molybdenum

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Molybdenum See Plans and Pricing Shaped catalyst for sour gas shift reactions and methods for using them Clariant Corporation (Louisville, KY) See Plans and Pricing
Molybdenum See Plans and Pricing Composite hollow particle, a method for making thereof, and a method for producing hydrogen gas King Abdulaziz University (Jeddah, SA) See Plans and Pricing
Molybdenum See Plans and Pricing Process for producing N-phosphonomethylglycine Monsanto Company (St. Louis, MO) See Plans and Pricing
Molybdenum See Plans and Pricing Overbased additives for lubricant oils containing a molybdenum complex, process for preparing them and compositions containing the said additives Societe Nationale Elf Aquitaine (Courbevoie, FR) See Plans and Pricing
Molybdenum See Plans and Pricing Apparatus for injection analysis of total inorganic phosphate Calgon Corporation (Pittsburgh, PA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Molybdenum

Drugname Country Document Number Estimated Expiration Related US Patent
Molybdenum China CN105665030 2034-12-08 See Plans and Pricing
Molybdenum Austria AT82576 2007-10-26 See Plans and Pricing
Molybdenum Australia AU2430288 2007-10-26 See Plans and Pricing
Molybdenum Australia AU594589 2007-10-26 See Plans and Pricing
Molybdenum Brazil BR8805503 2007-10-26 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Medtronic
McKesson
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.